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Farmington, ConnecticutABSTRACT Collapse and sudden death in physical training are the most serious complications of sickle cell trait (SCT). There
is evidence that erythrocytes in SCT patients aggregate during strenuous exercise, likely because of adhesive interactions with
the extracellular matrix (ECM) and endothelial cells, and because of their irregular viscoelastic properties. This results in inflam-
mation, blood flow impairment, and vaso-occlusive events. However, the exact role of stress conditions and how they lead to
these complications is virtually unknown. Using single-molecule atomic force microscopy experiments, we found that epineph-
rine, a hormone that is secreted under stressful conditions, increases both the frequency and strength of adhesion events
between basal cell adhesion molecule (BCAM/Lu) and ECM laminin, and between intercellular adhesion molecule-4
(ICAM-4) and endothelial avb3, compared with nonstimulated SCT erythrocytes. Increases in adhesion frequency provide signif-
icant evidence of the role of epinephrine in BCAM/Lu-laminin and ICAM-4-avb3 bonding, and suggest mechanisms of vaso-
occlusion during physical exertion in SCT.INTRODUCTIONSickle cell trait (SCT) is a risk factor for collapse and
sudden death during physical training (1–7). SCT is charac-
terized by the presence of both normal adult hemoglobin
(HbA) and abnormal sickle hemoglobin (HbS) in the red
blood cell (RBC, erythrocyte). SCT affects more than three
million people in the United States, ~40–50 times more than
sickle cell disease (SCD) (8). In HbS, the normal sequence
Val-His-Leu-Thr-Pro-Glu-Glu-Lys is changed to Val-His-
Leu-Thr-Pro-Val-Glu-Lys, with the amino acid valine
substituted for glutamic acid in the b6 site. The replacement
of two charged groups by two hydrophobic ones leads to
polymerization of deoxygenated Hb and to the formation
of stiff HbS fibers comprising a fibrous gel (9–11). Between
40% and 42% of the hemoglobin content of most individuals
with SCT is HbS (12). In contrast to homozygous SCD,
heterozygous SCT is traditionally regarded as a benign
condition (13–15). However, during strenuous exercise, indi-
viduals can develop a syndrome resembling SCD, with vaso-
occlusive events resulting from changes in the RBC
morphology, viscoelasticity, and adhesion (1,2,6,16–19).
Vaso-occlusion occurs in crises in which the arterial circula-
tion is blocked at one or many sites, leading to organ damage
and ischemic pain (20). Endothelial cell (EC) activation,
cytoadherence, inflammation, and coagulation activation
contribute to blood flow obstruction and play a critical role
in the pathophysiology of vaso-occlusion (21–23).
It is known that SCD RBCs adhere abnormally to extra-
cellular matrix (ECM) components and to ECs via changesSubmitted February 10, 2011, and accepted for publication January 27,
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mature erythrocytes express several adhesion receptors,
including the Lutheran (Lu) blood group RBC antigen; basal
cell adhesion molecule (BCAM), known as BCAM/Lu,
which is a high-affinity laminin receptor; and intercellular
adhesion molecule-4 (ICAM-4, LW glycoprotein), a
receptor for a number of integrins (24).
Although it is known that epinephrine enhances SCD
erythrocyte adhesion, the mechanism has not yet been quan-
titatively explored in SCT or SCD (25,26). Epinephrine is
a hormone that is secreted from the adrenal medulla during
periods of stress and strenuous exercise (27). Increased
circulating levels of epinephrine act on the RBC b2-adren-
ergic receptor, thereby activating Gas proteins that stimulate
adenylyl cyclase (AC). This enzyme catalyzes the conver-
sion of adenosine triphosphate (ATP) to cyclic adenosine
monophosphate (cAMP), leading to protein kinase A
(PKA) activation, an intermediate step in the upregulation
of BCAM/Lu- and ICAM-4-mediated adhesion (25,26,28).
The interaction of BCAM/Lu with the a5 chain of laminin
(LAMA5) on the ECM, as well as the interaction of
ICAM-4 with the avb3 integrin on ECs, may contribute to
vaso-occlusive events in SCD due to overexpression of
BCAM/Lu and ICAM-4 on SCD RBCs in the presence
and absence of epinephrine (24–26).MATERIALS AND METHODS
Preparation of BCAM/Lu and ICAM-4 substrate
To attach purified CD239 (Sigma Aldrich, St. Louis, MO), commonly
known as BCAM/Lu, onto a gold-coated mica substrate (Novascan Tech-
nologies, Ames, IA), we first incubated the substrate for 2 h in 50 mM mer-
captoethanesulfonate. Mercaptoethanesulfonate was prepared by addingdoi: 10.1016/j.bpj.2012.01.050
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The gold surface was allowed to dry, and then a drop of 1 mg/mL protein in
phosphate-buffered saline (PBS) was added to the surface. After 20 min, the
prepared gold surface was rinsed with PBS and a volume of PBS was added
for experiments. The same method was employed to attach ICAM-4-1
(Sigma Aldrich, St. Louis, MO) to a gold-coated mica substrate.Preparation of laminin and avb3 probes
Silicon nitride cantilevers were gently rinsed with ethanol and 18 MU
water before they were placed into a clean, dry petri dish with 30 mL
3-aminopropy-triethoxysilane (APTES) and 10 mL triethylamine for 1 h.
N3-dPEG-NH2 linker was prepared by adding dry methylene chloride
(0.5 mL), triethylamine (7 mL), and 7.5 mg (7.5 mL) of N3-dPEG-NH2
linker (Quanta Biodesign, Powell, OH) to a small, dry, glass vial. The
vial was sealed and inverted several times until all of the solid substances
dissolved. After the atomic force microscopy (AFM) probes were tightly
sealed with APTES for 1 h, they were removed and immediately added
to the N3-dPEG-NH2 linker at 4
C. After 1 h, the probes were rinsed
with methylene chloride, ethanol, and then 18 MU water. The probes
were placed in a parafilm-coated dish with their tips pointed upward and
inward in a circular manner. Then 50 mL of 250 mg/mL purified laminin
a5, clone 4C7 (Millipore, Temecula, CA), or 50 mL of 210 mg/mL purified
human integrin avb3 (Millipore, Temecula, CA) were added to the center of
the cantilevers, in contact with the probes. After 2 h, the AFM probes were
rinsed with PBS buffer.Erythrocyte preparation
The study included RBCs (Research Blood Components, Brighton, MA)
obtained from an adult subject with SCT (n¼ 1) and a healthy adult subject
(n ¼ 1). An Institutional Review Board–approved consent form was
obtained by the company for each donor that gave permission to use the
acquired sample for research purposes. Sodium citrate anticoagulant was
used, and the RBCs were used for experiments within 14 days of blood
draw and maintained at 4C before use. Cell age did not appear to have
an effect on the data. Erythrocytes were diluted to a concentration of
50% in Alsever’s solution (Sigma Aldrich, St. Louis, MO) and maintained
in 5% CO2 at 37
C before immobilization and experiments were
performed.Erythrocyte immobilization
Cells were immobilized on glass-bottomed petri dishes (MatTek, Ashland,
MA) coated with poly-L-lysine (PLL) to increase cell adherence. Then
150 ml of 1 mg/mL PLL solution (Sigma Aldrich, St. Louis, MO) were
allowed to adsorb for 5 min to a sterile glass surface, and excess solution
was drained away. RBCs of 50% concentration in Alsever’s solution
were allowed to adhere to each PLL-coated glass surface for 10 min in
the incubator (37C and 5% CO2). Unattached cells were removed by gentle
rinsing of the surface with Alsever’s solution at 25C, and a volume of
3.0 mL Alsever’s solution was added for experiments. For epinephrine-
mediated adhesion experiments, a volume of 3.0 mL of 10 nM epinephrine
(Sigma Aldrich, St. Louis, MO) was added.AFM measurements
Adhesion maps and force-distance curves were obtained with the use of an
Asylum MFP 3D-BIO atomic force microscope (Asylum Research, Santa
Barbara, CA) equipped with a liquid-cell setup. A petri dish heater was
employed to maintain the RBCs at physiological body temperature
(37C) during the experiments. The temperature inside the sample was
controlled (50.1C) via a closed-loop temperature control with an environ-Biophysical Journal 102(5) 1137–1143mental controller (Asylum Research, Santa Barbara, CA). Baseline
measurements were performed in Alsever’s solution at 37C. Epineph-
rine-mediated experiments were performed in a 10 nM epinephrine solu-
tion, using the Alsever’s solution as the base, at 37C. Unless otherwise
specified, we recorded all force measurements with a loading rate of
24,000 pN/s, which we calculated by multiplying the tip retraction velocity
(nm/s) by the spring constant of the cantilever (pN/nm).
The nominal spring constant kc of the employed cantilever was 30 pN/nm,
as provided by the manufacturer (Bruker Probes, Camarillo, CA). Exact
values for the cantilever spring constants were obtained via a thermal
noise-based method implemented by the manufacturer and were used in
all calculations. We chose this cantilever stiffness because it is known that
when kc>10 pN/nm, the soft linkage of the protein-protein interaction domi-
nates the behavior of the cantilever-protein effective spring system (29).
The approach and retraction velocities were held constant at 800 nm/s.
The probes had nominal tip radii of 20 nm and a nominal angle of 20, as
provided by the manufacturer.Statistical analysis
The reported adhesion interaction forces for the BCAM/Lu-laminin
complex and ICAM-4-avb3 complex in the text are average values obtained
via the Gaussian distribution. We assessed differences among the groups
using the two-tailed t-test for independent samples to evaluate the effects
of the SCT genotype and the epinephrine stimulation. The significance level
was defined as p < 0.05. The statistical analyses were conducted with the
Data Analysis Toolpack in Microsoft Excel (Microsoft, Redmond, WA).RESULTS
Dynamics of the BCAM/Lu-laminin
and ICAM-4-avb3 interaction
Direct measurements of the BCAM/Lu-laminin and ICAM-
4-avb3 adhesive interactions were obtained via single-mole-
cule force spectroscopy (30–32). Adhesive forces, defined
as the maximum rupture force (Fig. 1 B) associated with
the force-distance curves, were extracted from each of
1024 force curves that were acquired to determine the
rupture force. Upon investigation of the dynamics of the
BCAM/Lu-laminin interaction, force curves between
the LAMA5 tip and the BCAM/Lu-coated substrate were re-
corded at various retraction rates. The mean adhesion force
did not substantially depend on the loading rate applied
during retraction, over the experimentally tested range
(Fig. 1 C). The dynamics of the ICAM-4-avb3 interaction
showed a similar trend. This observation, in contrast to the
behavior of several other receptor-ligand complexes that
usually show an increase in adhesion force with the loga-
rithm of loading rate, indicates that the force measurements
were performed close to thermodynamic equilibrium (33).Interaction force of the BCAM/Lu-laminin
and ICAM-4-avb3 pairs
For the BCAM/Lu-laminin pair, force-distance curves were
recorded between the LAMA5 probe and the BCAM/
Lu-coated substrate. Adhesive forces were extracted from
each of the 1024 force curves acquired, and an average
FIGURE 1 Strategy for measuring the BCAM/Lu-laminin binding force
at the single-molecule level using AFM. (A) Schematic of the surface chem-
istry used to functionalize the AFM tip and substrate with LAMA5 and
BCAM/Lu. A PEG-linker was attached to an AFM tip terminated with
NH2 groups, and BCAM/Lu was bound to a gold substrate via mercaptoe-
thanesulfonate. (B) Force-distance curves are three representative examples
obtained using independent tips and substrates. The uppermost (blue) curve
demonstrates zero adhesive interaction, while the middle (red) and bottom
(black) curves show rupture forces associated with adhesion events. (C)
Dynamics of the BCAM/Lu-laminin interaction. Dependence of the adhe-
sion force on the loading rate applied during retraction, measured between
a LAMA5 tip and a BCAM/Lu substrate, while keeping the interaction time
(0 s) and loading rate during approach (24000 pN/s) constant. The mean
adhesion force does not notably change with the loading rate, indicating
the measurements were performed close to thermodynamic equilibrium.
A B
FIGURE 2 Measurement of the binding force of the BCAM/Lu-laminin
and ICAM-4-avb3 complexes. (A) Adhesion force histogram obtained from
1024 force curves (n ¼ 1024) measured in PBS between a LAMA5 tip and
a BCAM/Lu substrate. The distribution of adhesion forces reveals
a maximum value at 50 5 11 pN as determined by a Gaussian fit. The
frequency of adhesion events was 26%, as determined by the percentage
of curves showing rupture forces. The overlay shows the adhesion force
histogram (n ¼ 1024) obtained after injection of free laminin (250 mg/mL)
into the solution. The dramatic reduction of adhesion frequency and
broadening of the distribution reflect the blocking of the BCAM/Lu recep-
tors. (B) Adhesion force histogram obtained from 1024 force curves
(n ¼ 1024) measured in PBS between an integrin avb3 tip and a ICAM-4
substrate. The distribution of adhesion forces reveals a maximum value at
47 5 15 pN as determined by a Gaussian fit. The frequency of adhesion
events was 18%. The overlay shows the adhesion force histogram
(n ¼ 1024) obtained after injection of free integrin avb3 (210 mg/mL)
into the solution. The dramatic reduction of adhesion frequency reflects
the blocking of the ICAM-4 receptors.
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AFM, one can determine the specificity of ligand-receptor
binding by performing blocking experiments with free
ligands, which are injected into the solution to block the
receptor sites on the cell surface. Consequently, almost all
specific recognition signals completely disappear and only
occasional adhesion events are observed (30,34). We
demonstrated the specificity of the interaction by perform-
ing experiments in 250 mg/mL laminin solution, thus block-
ing the BCAM/Lu receptors. By recording force-distance
curves between the LAMA5 tip and the BCAM/Lu-coated
substrate in the laminin solution, we were able to show
that the percentage of curves exhibiting adhesion events
reduced dramatically from 26% to 6% (p < 106; Fig. 2 A).
For the ICAM-4-avb3 pair, force-distance curves were
recorded between the avb3 probe and the ICAM-4-coated
substrate, resulting in an average rupture force of 47 5
15 pN (Fig. 2 B). We demonstrated the specificity of the
interaction by performing experiments in 210 mg/mL integ-
rin avb3 solution, thus blocking the ICAM-4 receptors. Thepercentage of curves that showed adhesion events reduced
dramatically from 18% to 3% (p < 106; Fig. 2 B).Nonstimulated SCT RBC adhesion to laminin
and integrin avb3
In single erythrocytes we measured the effects of epineph-
rine on the bond strength and the frequency of binding
events between 1), the BCAM/Lu antigen, expressed on
the surface of SCT RBCs, and the laminin complex, ex-
pressed on the ECM; and 2), the ICAM-4 antigen expressed
on the surface of SCT RBCs, and the avb3 integrin,
expressed on ECs. We also measured the adhesion of nonsti-
mulated SCT RBCs compared with nonstimulated wild-type
(WT) RBCs. This method requires functionalization of the
AFM probe (30–32,35) with LAMA5 or integrin avb3 to
measure the interaction between the a5 chain of laminin
and BCAM/Lu receptor expressed on the tested RBC
(Fig. 3), or the interaction between integrin avb3 and
ICAM-4 receptor expressed on the tested RBC. From these
measurements, the distribution of the BCAM/Lu and
ICAM-4 receptor on the RBC surface is also obtained. We
placed the RBCs in an environment with a physiologically
relevant level of epinephrine to explore the effects of the
stress-induced epinephrine environment on the frequency
and distribution of adhesive interactions.
To detect the distribution of the receptors on the cell
surface, and to measure the physiologic BCAM/Lu-lamininBiophysical Journal 102(5) 1137–1143
FIGURE 3 AFM topographic image of a SCT erythrocyte displaying the
characteristic biconcave shape associated with healthy WT RBCs. This
erythrocyte is a representative example of the cells that were scanned
during experiments to map the distribution of BCAM/Lu and ICAM-4
receptors on human erythrocytes.
A B
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maps using a LAMA5 tip over 1 mm 1 mm areas. Adhesive
forces were extracted from each of the 1024 force curves
acquired from tests on n ¼ 6 WT and n ¼ 6 SCT erythro-
cytes. The average magnitude of the BCAM/Lu-laminin
bond was the same for WT and SCT (Fig. 4 A) erythrocytes:
46 5 6 pN and 46 5 10 pN, respectively. This bond
strength is also the same as the average rupture force of
50 5 11 pN (Fig. 2 A) measured between a BCAM/Lu-
coated gold substrate and a functionalized LAMA5 probe.
The number of observed binding events, however, shows
an increase from 10.42% to 16.89% (p < 0.05).A B
FIGURE 4 Measurement of the binding force of the BCAM/Lu-laminin
and ICAM-4-avb3 complexes on erythrocytes. (A) Foreground: Adhesion
force histogram obtained from 6144 force curves (n ¼ 6 cells  1024 force
curves) measured in Alsever’s solution between a LAMA5 tip and a WT
RBC. The distribution of adhesion forces reveals a maximum value at
465 6 pN, as determined by a Gaussian fit. Background: Adhesion force
histogram obtained from 6144 force curves (n ¼ 6 cells  1024 force
curves) obtained between a LAMA5 tip and a SCT RBC reveals a distribu-
tion of adhesion forces with a maximum value at 46 5 10 pN. The
frequency of adhesion events increased significantly from 10.42% on the
WT RBC to 16.89% on the SCT RBC (p< 0.05). (B) Foreground: Adhesion
force histogram obtained from 6144 force curves (n ¼ 6 cells  1024 force
curves) measured in Alsever’s solution between a avb3 tip and a WT RBC.
The distribution of adhesion forces reveals a maximum value at 46 5
10 pN, as determined by a Gaussian fit. Background: Adhesion force histo-
gram (n ¼ 6 cells  1024 force curves) obtained between a avb3 tip and
a SCT RBC reveals a distribution of adhesion forces with a maximum value
at 47 5 10 pN. There is a nonsignificant increase from 5.91% to 7.56%
(p > 0.05) in the number of adhesion events.
Biophysical Journal 102(5) 1137–1143For the measurements of the ICAM-4-avb3 pair bond
strength and local distribution, we extracted adhesive forces
from each of the 1024 force curves acquired from tests on
n ¼ 6 WT and n ¼ 6 SCT erythrocytes. The average magni-
tude of the ICAM-4-avb3 bond was the same for WT and
SCT (Fig. 4 B) erythrocytes: 465 10 pN and 475 10 pN,
respectively. This bond strength is also nearly the same as
the average rupture force of 475 15 pN (Fig. 2 B) measured
between an ICAM-4-coated gold substrate and a functional-
ized integrin avb3 probe. The number of observed binding
events showed an insignificant increase from 5.91% to
7.56% (p > 0.05).Epinephrine-stimulated SCT RBC adhesion
to laminin and integrin avb3
To test the hypothesis that an increase in epinephrine levels
results in an increase in the frequency of adhesive interac-
tions, we employed a similar approach. Treatment of WT
RBCs with 10 nM epinephrine, a physiologically relevant
level, induced an insignificant increase from 10.42% to
14.86% (p > 0.05) in the frequency of BCAM/Lu-laminin
binding events (n ¼ 6; Fig. 5 A), and an insignificant
increase from 5.91% to 8.99% (p > 0.05) in the frequencyFIGURE 5 Measurement of the physiologic implications of epinephrine-
stimulated adhesion. (A) Foreground: Adhesion force histogram (n ¼
6 cells  1024 force curves) obtained in 10 nM epinephrine between
a LAMA5 tip and a WT RBC reveals a distribution of adhesion forces
with a maximum value at 45 5 8 pN, comparable to the baseline value.
The frequency of adhesion events increased from 10.42% to 14.86%
(p > 0.05) as compared with baseline measurements of WT RBCs. Back-
ground: Adhesion force histogram (n ¼ 6 cells  1024 force curves)
obtained between aLAMA5 tip and an SCTRBC.The frequency of adhesion
events increased significantly from 16.89% to 35.04% (p < 0.01) as
compared with baseline measurements of SCT RBCs. The distribution
reveals a maximum value at 485 10 pN, comparable to the baseline SCT
value. (B) Foreground: Adhesion force histogram (n ¼ 6 cells 1024 force
curves) obtained in 10 nM epinephrine between an integrin avb3 tip and
a WT RBC reveals a distribution of adhesion forces with a maximum value
at 485 9 pN, comparable to the baseline value. The frequency of adhesion
events increased insignificantly from 5.91% to 8.99% (p > 0.05) as
comparedwith baselinemeasurements ofWTRBCs.Background:Adhesion
force histogram (n ¼ 6 cells  1024 force curves) obtained between an
integrin avb3 tip and an SCT RBC. The frequency of adhesion events
increased from 7.56% to 19.89% (p < 0.05) as compared with baseline
measurements of SCT RBCs. The distribution reveals a maximum value at
455 11 pN, comparable to the baseline value.
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no notable increase in the bond strength of either pair with
epinephrine stimulation. The specificity of the BCAM/
Lu-laminin interaction was validated via blocking experi-
ments (see Fig. S1 in the Supporting Material). By recording
force-distance curves between a LAMA5 tip and WT RBCs
in Alsever’s solution, we found that the percentage of curves
that showed adhesion events reduced dramatically from
10.42% to 0.52% (p < 0.001).
Treatment of SCT RBCs (n ¼ 6) with epinephrine
induced an increase in the frequency of BCAM/Lu-laminin
binding events from 16.89% to 35.04% (p < 0.01; Fig. 5 A).
In Fig. 5 A the distribution of the WT RBCs with epineph-
rine is overlaid on the distribution of the SCT RBCs with
epinephrine to demonstrate the broadened variability of
the Lu/BCAM-laminin adhesion force on the treated SCT
erythrocytes. Treatment of SCT RBCs (n¼ 6) with epineph-
rine induced an increase in the frequency of ICAM-4-avb3
binding events from 7.56% to 19.89% (p < 0.05; Fig. 5 B).
The distribution of the WT RBCs with epinephrine is
overlaid on the distribution of the SCT RBCs with epineph-
rine in Fig. 5 D to demonstrate the broadened variability of
the ICAM-4-avb3 adhesion force on the treated SCT
erythrocytes.
Of note, the 1 mm  1 mm spatially-resolved adhesion
maps reveal that the BCAM/Lu-mediated laminin binding
activity is not homogeneously distributed over the SCT
RBC surface, but rather is concentrated on nanodomains.
These nanodomains, often attributed to membrane rafts, are
only observed on SCT RBCs (n ¼ 6) in the presence of
epinephrine (Fig. 6 D). In contrast, WT RBCs (n ¼ 6) stim-
ulated with epinephrine (Fig. 6 C) show a nearly homoge-
neous distribution of BCAM/Lu receptors. Furthermore,
ICAM-4 receptor nanodomains are also observed, to a lesser
degree, on the SCT RBC (n ¼ 6) surface in the presence of
epinephrine (Fig. 6 H), with a heterogeneous receptor distri-
bution on the WT RBC (n ¼ 6) stimulated with epinephrine
(Fig. 6 G). In the nonstimulated environment, both WT
(Fig. 6, A and E) and SCT (Fig. 6, B and F) RBCs maintainA
B
C
D
E
F
G
Ha homogeneous distribution of BCAM/Lu and ICAM-4
receptors.DISCUSSION
Although it is known that the BCAM/Lu-laminin and
ICAM-4-avb3 binding complexes contribute to SCD vaso-
occlusion, the quantitative characteristics of these adhesion
interactions have not been explored in SCD or SCT erythro-
cytes. In WT RBCs and SCT RBCs, the magnitude of the
BCAM/Lu-laminin binding complex (46 5 6 pN and
46 plusmn; 10 pN, respectively) is equal to the average
rupture force of 505 11 pN recorded between a functional-
ized laminin probe and aBCAM/Lu-coated gold substrate. In
WT RBCs and SCT RBCs, the magnitude of the ICAM-
4-avb3 binding complex (46 5 10 pN and 47 5 10 pN,
respectively) is nearly the same as the average rupture force
of 47 5 15 pN recorded between a functionalized integrin
avb3 probe and an ICAM-4-coated gold substrate.
Interactions of receptor molecule cytoplasmic domains
with the cytoskeleton can play critical roles in adjusting
receptor function. It was previously determined that
BCAM/Lu has a high degree of connectivity to the erythro-
cyte membrane cytoskeleton via erythroid spectrin (36,37).
Of importance, disruption of the BCAM/Lu-spectrin linkage
is accompanied by enhanced cell adhesion to laminin (37).
A major finding of this study is that BCAM/Lu adhesion
events in SCT erythrocytes increased (p < 0.05) compared
with the WT. It is known that Hb interacts with the spectrin
network via band 3 (38,39), and the introduction of HbS was
recently found to have an effect on the mechanical proper-
ties of SCT erythrocytes (40). We conjecture that HbS
partially disrupts the spectrin network via its interaction
with band 3, indirectly disrupting the BCAM/Lu-spectrin
linkage. This results in increased diffusion and aggregation,
and thus significantly enhanced SCT RBC adhesion to ECM
laminin.
Epinephrine, acting through the b2-adrenergic receptor,
increases Lu-laminin a5 sickle-mediated red cell bindingFIGURE 6 Distribution of BCAM/Lu and
ICAM-4 on the surface of WT RBCs and SCT
RBCs using different probes and cell preparations.
(A and B) Adhesion force maps (color scale as
shown) recorded with LAMA5 functionalized
probes over WT RBCs (A) and SCT RBCs (B).
(C and D) Adhesion force maps recorded with
LAMA5 tips over WT RBCs (C) and SCT RBCs
(D) in 10 nM epinephrine. (E and F) Adhesion
force maps recorded with integrin avb3 probes
over WT RBCs (E) and SCT RBCs (F). (G and
H) Adhesion force maps recorded with integrin
avb3 tips over WT RBCs (G) and SCT RBCs (H)
in 10 nM epinephrine. Scale bars: 250 nm.
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1142 Maciaszek et al.via a cAMP- and PKA-dependent signaling pathway (25).
Further, the Lu cytoplasmic tail is phosphorylated in
epinephrine-stimulated sickle cells, which may be a critical
factor in sickle RBCs’ enhanced adhesion to laminin (41).
The BCAM cytoplasmic tail, which lacks the last 40 amino
acids of the sequence, does not undergo phosphorylation. It
was previously shown that PKA-mediated phosphorylation
of the Lu glycoprotein at Ser-621 positively regulates the
adhesion function of Lu under flow conditions (41).
Although the molecular basis for the resulting increased
adhesion is not yet understood, it was hypothesized that
phosphorylation of the Lu cytoplasmic tail weakens its
interaction with spectrin, enabling the freely-floating trans-
membrane Lu molecules to cluster and thereby generate
a larger adhesive force. A major result of this study is the
mapping of Lu nanodomains on epinephrine-stimulated
SCT erythrocytes, accompanied by an increase in the
frequency of binding events (p < 0.01) from the baseline
SCT erythrocytes. The significant broadening of the bond
magnitude distribution agrees with the aggregation of recep-
tors into nanodomains detected in Fig. 6 D. Although the
frequency of adhesive interactions increases on the WT
RBC in the stress-induced epinephrine environment, this
increase (from 10.42% to 14.86%) is not significant, and
receptor clustering is not observed (Fig. 6 C). This observa-
tion strengthens our conjecture that HbS disrupts the spectrin
network, resulting in aggregation of BCAM/Lu receptors in
SCT RBCs. Of note, receptor aggregation is not detected in
the case of SCT RBCs without epinephrine (Fig. 6 B).
ICAM-4-mediated binding to ECs and leukocytes is also
activated by epinephrine via stimulation of the b2-adren-
ergic receptor, which triggers a cAMP- and PKA-dependent
signaling pathway (42). In addition, ICAM-4 on epineph-
rine-stimulated sickle cells undergoes a significant increase
in serine phosphorylation, which may be a critical factor in
sickle RBCs’ enhanced adhesion to endothelial integrin
avb3 (26). It has been hypothesized that phosphorylation-
induced changes in the ICAM-4 cytoplasmic domain cause
a conformational change in its extracellular domain, thereby
generating a larger adhesive force. We observed an increase
in the frequency of binding events (p< 0.05) from the base-
line SCT erythrocytes (Fig. 5 D) on epinephrine-stimulated
SCT erythrocytes. Another important result of this study is
the quantification of the insignificant increase (p > 0.05)
of ICAM-4-avb3 adhesion events on the WT RBCs in the
stress-induced epinephrine environment (Fig. 5 B). This is
consistent with the fact that minimal ICAM-4 phosphoryla-
tion occurs in WT RBCs, due to an age-related reduction in
the cells’ ability to produce cAMP and thereby enhance
PKA activity in response to stimulation (25,43,44).
Although in this study we tested the effect of epinephrine
on single-molecule adhesion interactions that are thought
to contribute to vascular blockage in sickle cell vaso-occlu-
sion, epinephrine has also been found to work by increasing
RBC trapping in the spleen and liver (42,45).Biophysical Journal 102(5) 1137–1143CONCLUSIONS
The observed increases in adhesion frequency along with
the detected receptor aggregation into nanodomains provide
significant evidence of the role of epinephrine in enhancing
BCAM/Lu-laminin and ICAM-4-avb3 bond interactions.
These findings suggest a mechano-adhesive role for
epinephrine in the pathophysiology of vaso-occlusive inci-
dents related to sudden death in SCT individuals during
strenuous exercise.SUPPORTING MATERIAL
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